WEED Stock: Should You Buy Canopy Growth Right Now?

It might take a few years for Canopy Growth (TSX:WEED) stock to live up to its potential.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Canadian cannabis investors have experienced a wild and volatile ride in the past few years. First, investors were optimistic about marijuana legalization in Canada back in October 2018. Shares of pot producers were then trading near record highs, as market participants expected marijuana demand to explode.

Shares of Canopy Growth (TSX:WEED)(NYSE:CGC) soared from $2.44 a share in April 2016 to $70 in April 2019, a stellar rise of 2,800% in three years. However, soon after, investors realized that marijuana demand in Canada was impacted due to the slow rollout of retail stores in major provinces as well as a thriving black market.

Further, as is the case with several other nascent and high-growth industries, companies need to brace for a wave of competition that will impact top-line growth. The oversupply in the cannabis market resulted in high inventory levels, less-than-impressive revenue growth, million-dollar write-downs, and heavy losses.

Canopy Growth stock fell to a multi-year low of $15 in March 2020. While it has since recovered to trade at its current price of $40.2, let’s take a look to see if the pot heavyweight remains a solid bet right now for long-term investors.

Canopy Growth is backed by Constellation Brands

One clear advantage that Canopy Growth has over peers is the investment by U.S. beverage giant Constellation Brands. In October 2017, Constellation Brands invested $245 million in Canopy for a 9.9% stake. A year later, it invested another $5 billion in Canopy and, at the end of 2020, had a 38.6% stake in the latter.

In the December quarter, Canopy reported an EBITDA loss of $68 million compared with a loss of $97 million in the prior-year period. Canopy Growth can “afford” to remain unprofitable in the near term, as it ended CY 2020 with $825 million in cash, compared to its cash balance of $1.3 billion at the end of fiscal 2020.

It shows us that Canopy is burning $77.4 million each month on its operating and investing activities. So, the company has 11 months before which it will have to raise additional capital. Canopy Growth also has close to $800 million in short-term investments that can be sold to improve its liquidity position.

Earlier this year, Canopy Growth also filed a shelf prospectus allowing it to raise $2.5 billion over the next 25 months. It’s quite possible that the cannabis behemoth is keeping dry powder aside to aggressively expand south of the border once marijuana is legalized at the federal level.

Q3 sales were up 23% year over year

In the third quarter of fiscal 2021 that ended in December, Canopy’s net sales were up 23% year over year at $153 million. The company accounts for 15.7% of Canada’s recreational cannabis market and investors will be hoping for this figure to improve over the next few quarters.

In the next two years, Canopy Growth expects sales to increase at an annual rate of 40%, which will allow its earnings to expand and eventually turn profitable.

The investment of Constellation Brands positions Canopy Growth to gain a strong foothold in the cannabis-infused beverage market that might reach $2.8 billion by 2025.

While Canopy enjoys a leadership position in Canada’s marijuana market, it needs to narrow its losses and race to profitability to keep long-term investors interested. Cannabis legalization in the U.S. will take time but it will also be a massive driver for Canopy’s top-line growth.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Constellation Brands. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »